Overview

Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects

Status:
Completed
Trial end date:
2021-04-29
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of TSC as a treatment for participants who are infected with SARS-CoV-2 (COVID-19).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Diffusion Pharmaceuticals Inc
Treatments:
Trans-sodium crocetinate